Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Safety of transcranial focused ultrasound for human neuromodulation

View ORCID ProfileWynn Legon, Priya Bansal, Leo Ai, Jerel K Mueller, Gregg Meekins, Bernadette Gillick
doi: https://doi.org/10.1101/314856
Wynn Legon
University of Virginia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wynn Legon
  • For correspondence: wlegon@virginia.edu
Priya Bansal
University of Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leo Ai
University of Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jerel K Mueller
University of Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregg Meekins
University of Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernadette Gillick
University of Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Abstract

Background: Low intensity transcranial focused ultrasound (tFUS) is a new method of non-invasive neuromodulation that uses acoustic energy to affect neuronal excitability. tFUS offers high spatial resolution and adjustable focal lengths for precise neuromodulation of discrete regions in the human brain. Before the full potential of low intensity ultrasound for research and clinical application can be investigated, data on the safety of this technique is indicated. Objective/Hypothesis: To provide an initial evaluation of the safety of tFUS for human neuromodulation through participant report and neurological assessment surrounding pilot investigation of tFUS for neuromodulation. Methods: Participants (N = 120) that were enrolled in one of seven human ultrasound neuromodulation studies at the University of Minnesota (2015 to 2017) were queried to complete a follow-up Participant Report of Symptoms questionnaire assessing their self-reported experience and tolerance to participation in tFUS research and the perceived relation of symptoms to tFUS. Results: A total of 64/120 participant (53%) responded to follow-up requests to complete the Participant Report of Symptoms questionnaire. During the conduct of the seven studies in this report, none of the participants experienced serious adverse effects. From the post hoc assessment of safety using the questionnaire, 7/64 reported mild to moderate symptoms, that were perceived as possibly or probably related to participation in tFUS experiments. These reports included neck pain, problems with attention, muscle twitches and anxiety. The most common unrelated symptoms included sleepiness and neck pain. There were initial transient reports of mild neck pain, scalp tingling and headache that were extinguished upon follow-up. No new symptoms were reported upon follow up out to 1 month. Conclusions(s): To date, in the literature and including this report, no serious adverse events have been reported as a result of low intensity tFUS for human neuromodulation. Here, we report new data on minor transient events. As currently employed with the parameters used in the studies in this report, tFUS looks to be a safe form of transient neuromodulation in humans.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 04, 2018.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Safety of transcranial focused ultrasound for human neuromodulation
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
Share
Safety of transcranial focused ultrasound for human neuromodulation
Wynn Legon, Priya Bansal, Leo Ai, Jerel K Mueller, Gregg Meekins, Bernadette Gillick
bioRxiv 314856; doi: https://doi.org/10.1101/314856
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Safety of transcranial focused ultrasound for human neuromodulation
Wynn Legon, Priya Bansal, Leo Ai, Jerel K Mueller, Gregg Meekins, Bernadette Gillick
bioRxiv 314856; doi: https://doi.org/10.1101/314856

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neuroscience
Subject Areas
All Articles
  • Animal Behavior and Cognition (1002)
  • Biochemistry (1500)
  • Bioengineering (953)
  • Bioinformatics (6849)
  • Biophysics (2439)
  • Cancer Biology (1803)
  • Cell Biology (2539)
  • Clinical Trials (106)
  • Developmental Biology (1703)
  • Ecology (2585)
  • Epidemiology (1498)
  • Evolutionary Biology (5042)
  • Genetics (3627)
  • Genomics (4641)
  • Immunology (1184)
  • Microbiology (4260)
  • Molecular Biology (1629)
  • Neuroscience (10845)
  • Paleontology (83)
  • Pathology (242)
  • Pharmacology and Toxicology (410)
  • Physiology (559)
  • Plant Biology (1462)
  • Scientific Communication and Education (413)
  • Synthetic Biology (545)
  • Systems Biology (1882)
  • Zoology (261)